<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1"/><td>diclofenac</td><td ID="reaction1">stomach upset</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy2">tetracycline</td><td>Tetracycline</td><td ID="reaction2">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Flag</th><th>Notes</th></tr></thead><tbody><tr><td colspan="5"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 10:52:15 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result1_attr1">HEMOGLOBIN A1c</td><td>5.6</td><td>&lt;5.7 % of total Hgb</td><td>N</td><td ID="result1_attr1_notes"><p>For the purpose of screening for the presence of</p><p>diabetes:</p><p>&lt;5.7%       Consistent with the absence of diabetes</p><p>5.7-6.4%    Consistent with increased risk for diabetes</p><p>            (prediabetes)</p><p>&gt; or =6.5%  Consistent with diabetes</p><p>This assay result is consistent with a decreased risk</p><p>of diabetes.</p><p>Currently, no consensus exists regarding use of</p><p>hemoglobin A1c for diagnosis of diabetes in children.</p><p>According to American Diabetes Association (ADA)</p><p>guidelines, hemoglobin A1c &lt;7.0% represents optimal</p><p>control in non-pregnant diabetic patients. Different</p><p>metrics may apply to specific patient populations.</p><p>Standards of Medical Care in Diabetes(ADA).</p><p>This test was performed on the Roche cobas c503 platform.</p><p>Effective [REDACTED], a change in test platforms from the</p><p>[REDACTED] Architect to the Roche cobas c503 may have shifted</p><p>HbA1c results compared to historical results.</p><p>Based on laboratory validation testing conducted at</p><p>Quest, the Roche platform relative to the [REDACTED]</p><p>platform had an average increase in HbA1c value of</p><p>&lt; or = 0.3%. This difference is within accepted</p><p>variability established by the National Glycohemoglobin</p><p>Standardization Program. Note that not all individuals</p><p>will have had a shift in their results and direct</p><p>comparisons between historical and current results for</p><p>testing conducted on different platforms is not</p><p>recommended.</p></td></tr><tr><td colspan="5"><span class="content_span">Mammogram, Bilateral Screening (77067)</span><br/>Reviewed date:[REDACTED] 03:40:19 PM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/></td></tr><tr><td colspan="5"><span class="content_span">Midmark ECG (93000)</span><br/>Reviewed date:[REDACTED] 05:15:54 PM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/></td></tr><tr><td ID="result3_attr1">Heart Rate</td><td>61</td><td/><td/><td/></tr><tr><td ID="result3_attr2">RR_NumNormalBeats</td><td>0</td><td/><td/><td/></tr><tr><td ID="result3_attr3">Systolic Blood Pressure</td><td>122</td><td/><td/><td/></tr><tr><td ID="result3_attr4">Diastolic Blood Pressure</td><td>70</td><td/><td/><td/></tr><tr><td ID="result3_attr5">PR Interval</td><td>148</td><td/><td/><td/></tr><tr><td ID="result3_attr6">QT Interval</td><td>416</td><td/><td/><td/></tr><tr><td ID="result3_attr7">QTc Interval</td><td>417</td><td/><td/><td/></tr><tr><td ID="result3_attr8">QRS Duration</td><td>80</td><td/><td/><td/></tr><tr><td ID="result3_attr9">PWave Axis</td><td>35</td><td/><td/><td/></tr><tr><td ID="result3_attr10">QrsWave Axis</td><td>-15</td><td/><td/><td/></tr><tr><td ID="result3_attr11">TWave Axis</td><td>90</td><td/><td/><td/></tr><tr><td ID="result3_attr12">Mean Heart Rate</td><td>0</td><td/><td/><td/></tr><tr><td ID="result3_attr13">Diastolic Blood Pressure</td><td>0</td><td/><td/><td/></tr><tr><td ID="result3_attr14">Systolic Blood Pressure</td><td>0</td><td/><td/><td/></tr><tr><td ID="result3_attr15">MeanRR Interval</td><td>0</td><td/><td/><td/></tr><tr><td ID="result3_attr16">MinRR Interval</td><td>0</td><td/><td/><td/></tr><tr><td ID="result3_attr17">MaxRR Interval</td><td>0</td><td/><td/><td/></tr><tr><td ID="result3_attr18">NumBeats</td><td>0</td><td/><td/><td/></tr><tr><td colspan="5"><span class="content_span">URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020)</span><br/>Reviewed date:[REDACTED] 10:52:16 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result4_attr1">COLOR</td><td>YELLOW</td><td>YELLOW</td><td>N</td><td/></tr><tr><td ID="result4_attr2">APPEARANCE</td><td>CLEAR</td><td>CLEAR</td><td>N</td><td/></tr><tr><td ID="result4_attr3">SPECIFIC GRAVITY</td><td>1.006</td><td>1.001-1.035</td><td>N</td><td/></tr><tr><td ID="result4_attr4">PH</td><td>7.5</td><td>5.0-8.0</td><td>N</td><td/></tr><tr><td ID="result4_attr5">GLUCOSE</td><td>NEGATIVE</td><td>NEGATIVE</td><td>N</td><td/></tr><tr><td ID="result4_attr6">BILIRUBIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td>N</td><td/></tr><tr><td ID="result4_attr7">KETONES</td><td>NEGATIVE</td><td>NEGATIVE</td><td>N</td><td/></tr><tr><td ID="result4_attr8">OCCULT BLOOD</td><td>NEGATIVE</td><td>NEGATIVE</td><td>N</td><td/></tr><tr><td ID="result4_attr9">PROTEIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td>N</td><td/></tr><tr><td ID="result4_attr10">NITRITE</td><td>NEGATIVE</td><td>NEGATIVE</td><td>N</td><td/></tr><tr><td ID="result4_attr11">LEUKOCYTE ESTERASE</td><td>1+</td><td>NEGATIVE</td><td>A</td><td/></tr><tr><td ID="result4_attr12">WBC</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td>N</td><td/></tr><tr><td ID="result4_attr13">RBC</td><td>NONE SEEN</td><td>&lt; OR = 2 /HPF</td><td>N</td><td/></tr><tr><td ID="result4_attr14">SQUAMOUS EPITHELIAL CELLS</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td>N</td><td/></tr><tr><td ID="result4_attr15">BACTERIA</td><td>NONE SEEN</td><td>NONE SEEN /HPF</td><td>N</td><td/></tr><tr><td ID="result4_attr16">HYALINE CAST</td><td>NONE SEEN</td><td>NONE SEEN /LPF</td><td>N</td><td/></tr><tr><td ID="result4_attr17">NOTE</td><td/><td/><td/><td ID="result4_attr17_notes"><p>This urine was analyzed for the presence of WBC,</p><p>RBC, bacteria, casts, and other formed elements.</p><p>Only those elements seen were reported.</p></td></tr><tr><td ID="result4_attr18">REFLEXIVE URINE CULTURE</td><td/><td/><td/><td ID="result4_attr18_notes"><p/><p>  CULTURE, URINE, ROUTINE</p><p>  Micro Number:      21749611</p><p>  Test Status:       Final</p><p>  Specimen Source:   Urine</p><p>  Specimen Quality:  Adequate</p><p>  Result:            No Growth</p><p>CULTURE INDICATED - RESULTS TO FOLLOW</p></td></tr><tr><td ID="result4_attr19">CULTURE, URINE, ROUTINE</td><td>SEE NOTE</td><td/><td/><td ID="result4_attr19_notes"><p/><p>  CULTURE, URINE, ROUTINE</p><p>  Micro Number:      21749611</p><p>  Test Status:       Final</p><p>  Specimen Source:   Urine</p><p>  Specimen Quality:  Adequate</p><p>  Result:            No Growth</p><p>CULTURE INDICATED - RESULTS TO FOLLOW</p></td></tr><tr><td colspan="5"><span class="content_span">PROTHROMBIN W/INR + PARTIAL THROMBOPLASTIN TIMES (4914)</span><br/>Reviewed date:[REDACTED] 10:52:16 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result5_attr1">PARTIAL THROMBOPLASTIN TIME, ACTIVATED</td><td>26</td><td>23-32 sec</td><td>N</td><td ID="result5_attr1_notes"><p/><p>This test has not been validated for monitoring</p><p>unfractionated heparin therapy. For testing that</p><p>is validated for this type of therapy, please refer</p><p>to the Heparin Anti-Xa assay (test code 30292).</p><p>For additional information, please refer to</p><p>http://education.QuestDiagnostics.com/faq/FAQ159</p><p>(This link is being provided for</p><p>informational/educational purposes only.)</p></td></tr><tr><td ID="result5_attr2">INR</td><td>1.0</td><td/><td>N</td><td ID="result5_attr2_notes"><p>Reference Range                     0.9-1.1</p><p>Moderate-intensity Warfarin Therapy 2.0-3.0</p><p>Higher-intensity Warfarin Therapy   3.0-4.0</p></td></tr><tr><td ID="result5_attr3">PT</td><td>10.4</td><td>9.0-11.5 sec</td><td>N</td><td/></tr><tr><td colspan="5"><span class="content_span">BASIC METABOLIC PANEL (10165)</span><br/>Reviewed date:[REDACTED] 10:52:16 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result6_attr1">GLUCOSE</td><td>95</td><td>65-99 mg/dL</td><td>N</td><td ID="result6_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result6_attr2">UREA NITROGEN (BUN)</td><td>16</td><td>7-25 mg/dL</td><td>N</td><td/></tr><tr><td ID="result6_attr3">CREATININE</td><td>0.47</td><td>0.60-1.00 mg/dL</td><td>L</td><td/></tr><tr><td ID="result6_attr4">EGFR</td><td>98</td><td>&gt; OR = 60 mL/min/1.73m2</td><td>N</td><td/></tr><tr><td ID="result6_attr5">BUN/CREATININE RATIO</td><td>34</td><td>6-22 (calc)</td><td>H</td><td/></tr><tr><td ID="result6_attr6">SODIUM</td><td>141</td><td>135-146 mmol/L</td><td>N</td><td/></tr><tr><td ID="result6_attr7">POTASSIUM</td><td>4.3</td><td>3.5-5.3 mmol/L</td><td>N</td><td/></tr><tr><td ID="result6_attr8">CHLORIDE</td><td>106</td><td>98-110 mmol/L</td><td>N</td><td/></tr><tr><td ID="result6_attr9">CARBON DIOXIDE</td><td>27</td><td>20-32 mmol/L</td><td>N</td><td/></tr><tr><td ID="result6_attr10">CALCIUM</td><td>9.2</td><td>8.6-10.4 mg/dL</td><td>N</td><td/></tr><tr><td colspan="5"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 10:52:16 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING; NON-FASTING; NON-FASTING; NON-FASTING; NON-FAST<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result7_attr1">WHITE BLOOD CELL COUNT</td><td>6.5</td><td>3.8-10.8 Thousand/uL</td><td>N</td><td/></tr><tr><td ID="result7_attr2">RED BLOOD CELL COUNT</td><td>4.73</td><td>3.80-5.10 Million/uL</td><td>N</td><td/></tr><tr><td ID="result7_attr3">HEMOGLOBIN</td><td>13.5</td><td>11.7-15.5 g/dL</td><td>N</td><td/></tr><tr><td ID="result7_attr4">HEMATOCRIT</td><td>41.6</td><td>35.0-45.0 %</td><td>N</td><td/></tr><tr><td ID="result7_attr5">MCV</td><td>87.9</td><td>80.0-100.0 fL</td><td>N</td><td/></tr><tr><td ID="result7_attr6">MCH</td><td>28.5</td><td>27.0-33.0 pg</td><td>N</td><td/></tr><tr><td ID="result7_attr7">MCHC</td><td>32.5</td><td>32.0-36.0 g/dL</td><td>N</td><td/></tr><tr><td ID="result7_attr8">RDW</td><td>13.2</td><td>11.0-15.0 %</td><td>N</td><td/></tr><tr><td ID="result7_attr9">PLATELET COUNT</td><td>210</td><td>140-400 Thousand/uL</td><td>N</td><td/></tr><tr><td ID="result7_attr10">MPV</td><td>11.6</td><td>7.5-12.5 fL</td><td>N</td><td/></tr><tr><td ID="result7_attr11">ABSOLUTE NEUTROPHILS</td><td>4199</td><td>1500-7800 cells/uL</td><td>N</td><td/></tr><tr><td ID="result7_attr12">ABSOLUTE LYMPHOCYTES</td><td>1645</td><td>850-3900 cells/uL</td><td>N</td><td/></tr><tr><td ID="result7_attr13">ABSOLUTE MONOCYTES</td><td>468</td><td>200-950 cells/uL</td><td>N</td><td/></tr><tr><td ID="result7_attr14">ABSOLUTE EOSINOPHILS</td><td>117</td><td>15-500 cells/uL</td><td>N</td><td/></tr><tr><td ID="result7_attr15">ABSOLUTE BASOPHILS</td><td>72</td><td>0-200 cells/uL</td><td>N</td><td/></tr><tr><td ID="result7_attr16">NEUTROPHILS</td><td>64.6</td><td/><td>N</td><td/></tr><tr><td ID="result7_attr17">LYMPHOCYTES</td><td>25.3</td><td/><td>N</td><td/></tr><tr><td ID="result7_attr18">MONOCYTES</td><td>7.2</td><td/><td>N</td><td/></tr><tr><td ID="result7_attr19">EOSINOPHILS</td><td>1.8</td><td/><td>N</td><td/></tr><tr><td ID="result7_attr20">BASOPHILS</td><td>1.1</td><td/><td>N</td><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div>No Information</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Meclizine HCl 25 MG Tablet</td><td ID="instruction1">1 tablet as needed Orally every 12 hrs; Duration: 30 days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication2">Doxepin HCl 3 MG Tablet</td><td ID="instruction2">1 tablet at bedtime Orally Once a day; Duration: 30 days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication3">traZODone HCl 50 MG Tablet</td><td ID="instruction3">1 tablet at bedtime as needed Orally Once a day; Duration: 30 days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication4">cloNIDine HCl 0.1 MG Tablet</td><td ID="instruction4">1 tablet Orally Once a day; Duration: 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Rosuvastatin Calcium 20 MG Tablet</td><td ID="instruction5">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Lisinopril 10 MG Tablet</td><td ID="instruction6">1 tab(s) orally once a day; Duration: 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Metoprolol Succinate ER 25 mg tablet, extended release</td><td ID="instruction7">TAKE 1 TABLET BY MOUTH EVERY DAY</td><td ID="medication7notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Active</td></tr><tr><td ID="medication8">cloNIDine HCl 0.1 MG Tablet</td><td ID="instruction8"><p>1 tablet Orally Once a day; Duration: 30 days</p><p>As needed for blood pressure greater than 160/90</p></td><td/><td>[REDACTED]</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">Influenza, Fluzone High Dose Quad</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization1notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization2">Influenza, Fluzone High Dose Quad</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Social History</span><table ID="socialhistorynotes" width="100%" border="1"><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Drugs/Alcohol:</th></tr><tr><th>Social Info</th><th>Question</th><th>Answer</th><th>Notes</th></tr><tr><td>Drugs</td><td>Have you used drugs other than those for medical reasons in the past 12 months?</td><td>No</td><td/></tr><tr><td>Caffeine</td><td>Intake:</td><td>1-2 cups per day</td><td/></tr></tbody><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Drug/Alcohol (SmartForms):</th></tr><tr><th>Social Info</th><th>Question</th><th>Answer</th><th>Notes</th></tr><tr><td rowspan="6">AUDIT-C (Standard)</td><td>Did you have a drink containing alcohol in the past year?</td><td>Yes</td><td/></tr><tr><td> ∟How often did you have a drink containing alcohol in the past year?</td><td>2 to 4 times a month (2 points)</td><td/></tr><tr><td> ∟How many drinks did you have on a typical day when you were drinking in the past year?</td><td>1 or 2 drinks (0 point)</td><td/></tr><tr><td> ∟How often did you have six or more drinks on one occasion in the past year?</td><td>Never (0 point)</td><td/></tr><tr><td>Points</td><td>2</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Tobacco Use:</th></tr><tr><th>Social Info</th><th>Question</th><th>Answer</th><th>Notes</th></tr><tr><td>Tobacco Control (Standard)</td><td>Tobacco use:</td><td>Nonsmoker</td><td/></tr></tbody><tbody><tr><td colspan="4"/></tr><tr><th colspan="4">Additional Details</th></tr><tr><th>Category</th><th>Social Info</th><th>Options</th><th>Details</th></tr><tr><td rowspan="2">Drugs/Alcohol:</td><td>Do you smoke marijuana?</td><td/><td>Denies</td></tr><tr><td>Do you drink alcohol?</td><td/><td>seldom</td></tr><tr><td>Migrated Social History</td><td>Migrated Social History</td><td/><td><p>;(Exercise:):yes frequency: couple of times per week </p><p> </p><p>;(Living Will):yes son advance directive - [REDACTED] and [REDACTED] </p><p> </p><p>;(Organ Donation):no </p><p> </p><p>;(Recreational drug use:):no</p></td></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Primary insomnia (3972004)</td><td ID="Problem1">Primary insomnia (F51.01)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hypertensive heart disease without congestive heart failure (60899001)</td><td ID="Problem2">Hypertensive heart disease without heart failure (I11.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Essential hypertension (59621000)</td><td ID="Problem3">Essential (primary) hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hypercoagulable state (76612001)</td><td ID="Problem4">Hypercoagulable state (D68.59)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Cataract (193570009)</td><td ID="Problem5">Cataract, unspecified cataract type, unspecified laterality (H26.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Glaucoma (23986001)</td><td ID="Problem6">Glaucoma, unspecified glaucoma type, unspecified laterality (H40.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hyperlipidaemia (55822004)</td><td ID="Problem7">Hyperlipidemia, unspecified hyperlipidemia type (E78.5)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Angina co-occurrent and due to coronary arteriosclerosis (15960141000119102)</td><td ID="Problem8">Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris (I25.118)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Vitamin D deficiency (34713006)</td><td ID="Problem9">Vitamin D deficiency (E55.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Aortic valve sclerosis (67754003)</td><td ID="Problem10">Aortic valve sclerosis (I35.8)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Atrial fibrillation (49436004)</td><td ID="Problem11">PAF (paroxysmal atrial fibrillation) (I48.0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Osteoarthritis of knee (239873007)</td><td ID="Problem12">Primary osteoarthritis of both knees (M17.0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Acquired hypothyroidism (111566002)</td><td ID="Problem13">Acquired hypothyroidism (E03.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Osteoarthritis of knee (239873007)</td><td ID="Problem14">Primary osteoarthritis of left knee (M17.12)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Non-rheumatic mitral regurgitation (194978002)</td><td ID="Problem15">Non-rheumatic mitral regurgitation (I34.0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Age-related osteoporosis (276661002)</td><td ID="Problem16">Osteoporosis, unspecified osteoporosis type, unspecified pathological fracture presence (M81.0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Cataract (193570009)</td><td ID="Problem17">CATARACT OF BOTH EYES, UNSPECIFIED CATARACT TYPE (H26.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Gastroesophageal reflux disease (235595009)</td><td ID="Problem18">GERD (GASTROESOPHAGEAL REFLUX DISEASE) (K21.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Subclinical hypothyroidism (54823002)</td><td ID="Problem19">Subclinical hypothyroidism (E03.8)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td/><td ID="Problem20">Disorder of artery or arteriole (I77.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Cardiomegaly (8186001)</td><td ID="Problem21">Mild concentric left ventricular hypertrophy (LVH) (I51.7)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td/><td ID="Problem22">Degenerative disorder of central nervous system (G31.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>63 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital2">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital3">Height-cm</th><td>149.86 cm</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital4">Oximetry</th><td>97 %</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital5">Blood pressure diastolic</th><td>80 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital6">Weight-kg</th><td>54.43 kg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital7">Height</th><td>59 in</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital8">Blood pressure systolic</th><td>130 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital9">Weight</th><td>120 lbs</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital10">BMI</th><td>24.23 kg/m2</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Screening mammogram, encounter for Z12.31</td></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Essential (primary) hypertension I10</td></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Preoperative clearance Z01.818 ; CATARACT OF BOTH EYES, UNSPECIFIED CATARACT TYPE H26.9 ; Hypertensive heart disease without heart failure I11.9 ; PAF (paroxysmal atrial fibrillation) I48.0 ; Acquired hypothyroidism E03.9 and Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris I25.118</td></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Pre-op testing Z01.818 ; Primary osteoarthritis of left knee M17.12 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; PAF (paroxysmal atrial fibrillation) I48.0 ; Mild concentric left ventricular hypertrophy (LVH) I51.7 ; IMPAIRED FASTING BLOOD SUGAR R73.01 ; Acquired hypothyroidism E03.9 ; Hypercoagulable state D68.59 ; Hypertensive heart disease without heart failure I11.9 and Degenerative disorder of central nervous system G31.9</td></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>DIZZINESS, NONSPECIFIC R42</td></tr><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Hypertensive heart disease without heart failure I11.9 ; PAF (paroxysmal atrial fibrillation) I48.0 ; IMPAIRED FASTING BLOOD SUGAR R73.01 ; Acquired hypothyroidism E03.9 ; Non-rheumatic mitral regurgitation I34.0 ; Glaucoma, unspecified glaucoma type, unspecified laterality H40.9 and Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris I25.118</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Pre-op testing (ICD-10 - Z01.818)</td><td/><td><p>Patient presented to clinic for preoperative evaluation undergo left total knee replacement with [REDACTED] on [REDACTED] with HSS under general anesthesia.</p><p>EKG was performed shows sinus rhythm with no definitive evidence of coronary ischemia or arrhythmias.  Patient was requested to get cardiovascular clearance.  As per patient cardiovascular clearance was obtained and sent to surgeon.</p><p>Preoperative labs and chest x-ray will be ordered.</p></td><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Primary osteoarthritis of left knee (ICD-10 - M17.12)</td><td/><td><p>Patient presented to clinic for preoperative evaluation undergo left total knee replacement with [REDACTED] on [REDACTED] with HSS under general anesthesia.</p><p>EKG was performed shows sinus rhythm with no definitive evidence of coronary ischemia or arrhythmias.  Patient was requested to get cardiovascular clearance by the surgeon.</p></td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>DIZZINESS, NONSPECIFIC (ICD-10 - R42)</td><td/><td>see hpi</td><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Screening mammogram, encounter for (ICD-10 - Z12.31)</td><td/><td/><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td/><td>Hypercholesterolemia continue statin.</td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Hypertensive heart disease without heart failure (ICD-10 - I11.9)</td><td/><td><p>Advised patient to refrain from eating excess salt, (recommend adherence to treatment and low sodium diet.) Low sodium diet reviewed with patient, monitor daily B/P at home and record. If it is greater than 140/90's consistently to call the office for further evaluation. Will continue to monitor.</p><p>Start clonidine</p></td><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Preoperative clearance (ICD-10 - Z01.818)</td><td/><td><p>Patient presented to clinic for preoperative evaluation to undergo bilateral cataract surgery on [REDACTED] and [REDACTED] [REDACTED] Eye Institute by [REDACTED].</p><p>At this point to the best of my knowledge the patient is considered medically stable to undergo the specified surgical procedure in an ambulatory setting and may proceed as indicated at the surgeon's discretion</p></td><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>CATARACT OF BOTH EYES, UNSPECIFIED CATARACT TYPE (ICD-10 - H26.9)</td><td/><td>managed by Opht</td><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Hypertensive heart disease without heart failure (ICD-10 - I11.9)</td><td/><td><p>Advised patient to refrain from eating excess salt, (recommend adherence to treatment and low sodium diet.) Low sodium diet reviewed with patient, monitor daily B/P at home and record. If it is greater than 140/90's consistently to call the office for further evaluation. Will continue to monitor.</p><p>Cont clonidine</p></td><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>PAF (paroxysmal atrial fibrillation) (ICD-10 - I48.0)</td><td/><td>Managed by cardiology currently on metoprolol.  No anticoagulation</td><td/><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td/><td>Hypercholesterolemia continue statin.</td><td/><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>PAF (paroxysmal atrial fibrillation) (ICD-10 - I48.0)</td><td/><td>Managed by cardiology currently on metoprolol.  No anticoagulation</td><td/><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>IMPAIRED FASTING BLOOD SUGAR (ICD-10 - R73.01)</td><td/><td>Recommend dietary modifications</td><td/><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>PAF (paroxysmal atrial fibrillation) (ICD-10 - I48.0)</td><td/><td>Managed by cardiology currently on metoprolol.  No anticoagulation</td><td/><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Acquired hypothyroidism (ICD-10 - E03.9)</td><td/><td>Follow-up labs, no treatment</td><td/><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Acquired hypothyroidism (ICD-10 - E03.9)</td><td/><td>Follow-up labs, no treatment</td><td/><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Mild concentric left ventricular hypertrophy (LVH) (ICD-10 - I51.7)</td><td/><td>Left ventricular hypertrophy noted on imaging.  Managed by cardiology.</td><td/><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>IMPAIRED FASTING BLOOD SUGAR (ICD-10 - R73.01)</td><td/><td>Recommend dietary modifications</td><td/><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Non-rheumatic mitral regurgitation (ICD-10 - I34.0)</td><td/><td>Mitral valve regurgitation managed by cardiology</td><td/><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris (ICD-10 - I25.118)</td><td/><td>Stable</td><td/><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Glaucoma, unspecified glaucoma type, unspecified laterality (ICD-10 - H40.9)</td><td/><td>Followed by ophthalmology</td><td/><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Acquired hypothyroidism (ICD-10 - E03.9)</td><td/><td>Follow-up labs, no treatment</td><td/><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Hypercoagulable state (ICD-10 - D68.59)</td><td/><td>due to Afib</td><td/><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris (ICD-10 - I25.118)</td><td/><td/><td/><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>Hypertensive heart disease without heart failure (ICD-10 - I11.9)</td><td/><td>Advised patient to refrain from eating excess salt, (recommend adherence to treatment and low sodium diet.) Low sodium diet reviewed with patient, monitor daily B/P at home and record. If it is greater than 140/90's consistently to call the office for further evaluation. Will continue to monitor.</td><td/><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Degenerative disorder of central nervous system (ICD-10 - G31.9)</td><td/><td>CNS degeneration on MRI</td><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">X ray : Chest (PA lateral)</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 01:40:00 PM, [REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Humana Medicare PPO</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>H51898449</td><td/><td>[REDACTED]</td><td>Self - patient is the insured</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>Essential (primary) hypertension</td><td>I10</td></tr><tr><td>GERD (gastroesophageal reflux disease)</td><td>K21.9</td></tr><tr><td>Primary osteoarthritis of both knees</td><td>M17.0</td></tr><tr><td>Coronary artery disease involving native coronary artery of native heart with angina pectoris</td><td>I25.119</td></tr><tr><td>Hyperlipidemia, unspecified hyperlipidemia type</td><td>E78.5</td></tr><tr><td>PAF (paroxysmal atrial fibrillation)</td><td>I48.0</td></tr><tr><td>Primary insomnia</td><td>F51.01</td></tr><tr><td>Left breast mass</td><td>N63</td></tr><tr><td>Mild concentric left ventricular hypertrophy (LVH)</td><td>I51.7</td></tr><tr><td>Osteoporosis</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>c-section x2</td><td/></tr><tr><td>stem cell procedure bilateral knee</td><td>6/2018</td></tr></tbody></table><span class="content_span">Hospitalization History</span><table width="100%" border="1"><thead><tr><th>Reason</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>afib</td><td>3/2018</td></tr></tbody></table></div><br/><br/>
</body></html>